×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Japan Medical Deviceical Second Opinion Market

ID: MRFR/HC/42311-HCR
200 Pages
MRFR Team
March 2025

Japan Medical Device Second Opinion Market

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

Japan Medical Deviceical Second Opinion Market Summary

Industry Developments

Recent developments in the Japan Medical Device Second Opinion Market indicate a growing emphasis on advanced imaging and diagnostic technologies. Companies such as Siemens Healthineers and GE Healthcare continue to innovate, enhancing their offerings in medical imaging to support second opinions in critical healthcare decisions. In September 2023, Fujifilm announced a partnership with Terumo aimed at integrating their diagnostic tools to improve patient outcomes and streamline second opinions across medical facilities in Japan. Additionally, Olympus is advancing its endoscope technology to facilitate easier second-opinion consultations for gastrointestinal issues. In terms of market dynamics, Roche Diagnostics noted a significant increase in demand for second opinion services due to rising awareness about patient-centered care. Mergers within the sector include Canon Medical Systems acquiring certain assets of a smaller diagnostics firm in May 2023 to bolster its portfolio. This activity reflects ongoing consolidation in the market, with companies like Mitsubishi Electric and Hitachi Medical Systems actively looking for strategic partnerships to broaden their technological capabilities. Overall, these developments position Japan’s medical device sector for robust growth as advanced diagnostics become integral to healthcare delivery.

Report Scope

Report Scope: ,,,,,,,,,,,,,
Report Attribute/Metric Source:Details
MARKET SIZE 20180.18(USD Billion)
MARKET SIZE 20240.21(USD Billion)
MARKET SIZE 20350.92(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 14.31% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Billion
KEY COMPANIES PROFILEDSiemens Healthineers, Terumo, Philips Healthcare, Canon Medical Systems, SHIMADZU, Fujifilm, Roche Diagnostics, GE Healthcare, Hitachi Medical Systems, Nipro, Asahi Kasei Medical, Mitsubishi Electric, Olympus, Mizuho Medical
SEGMENTS COVEREDApplication Outlook, Source of Service Outlook, Services Outlook, Type Outlook
KEY MARKET OPPORTUNITIESTelemedicine integration, Growing aging population, Rising chronic diseases, Increased healthcare spending, Demand for personalized care
KEY MARKET DYNAMICSincreasing patient awareness, technological advancements, regulatory challenges, competitive landscape, rising healthcare costs
COUNTRIES COVEREDJapan

Leave a Comment

FAQs

What is the expected market size of the Japan Medical Device Second Opinion Market in 2024?

The market is expected to be valued at 0.21 USD Billion in 2024.

What is the forecasted market size for the Japan Medical Device Second Opinion Market by 2035?

The expected market size for 2035 is 0.92 USD Billion.

What is the projected CAGR for the Japan Medical Device Second Opinion Market from 2025 to 2035?

The market is anticipated to grow at a CAGR of 14.31% from 2025 to 2035.

Which application segment is expected to hold the largest market share in 2035?

The Cancer application segment is projected to be valued at 0.20 USD Billion in 2035.

What are the key players in the Japan Medical Device Second Opinion Market?

Major players include Siemens Healthineers, Terumo, Philips Healthcare, and GE Healthcare.

How much is the Diabetes application segment expected to be valued in 2035?

The Diabetes application segment is projected to reach 0.16 USD Billion in 2035.

What is the expected market value for Cardiac Disorders in 2024?

The market value for Cardiac Disorders is anticipated to be 0.06 USD Billion in 2024.

What growth opportunities exist in the Japan Medical Device Second Opinion Market?

The market presents opportunities driven by technological advancements and rising healthcare demands.

What is the anticipated market value for Neurological Disorders in 2035?

The Neurological Disorders segment is projected to be valued at 0.12 USD Billion in 2035.

How will the Respiratory Disorders segment perform from 2024 to 2035?

The Respiratory Disorders segment is expected to grow from 0.03 USD Billion in 2024 to 0.20 USD Billion in 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions